PennsylvaniaSB 9462025-2026 Regular SessionSenate

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and providing for . . . tianeptine-related adverse health events.

Sponsored By: Doug Mastriano (Republican)

In Committee

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Doug Mastriano

    Republican • Senate

Cosponsors

  • Amanda M. Cappelletti

    Democratic • Senate

  • Daniel Laughlin

    Republican • Senate

  • Maria Collett

    Democratic • Senate

  • Michele Brooks

    Republican • Senate

  • Nick Miller

    Democratic • Senate

  • Tracy Pennycuick

    Republican • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to Health & Human Services

    7/23/2025Senate

Bill Text

Related Bills

Back to State Legislation